The European Tribune is a forum for thoughtful dialogue of European and international issues. You are invited to post comments and your own articles.
Please REGISTER to post.
EU contract did not leave time to fix vaccine hiccups -AstraZeneca CEO AstraZeneca's Chief Executive on Tuesday said the European Union's late decision to strike a contract with the drugmaker to supply COVID-19 vaccines, months after Britain, meant the company did not have enough time to iron out glitches in setting up production lines with external partners. "We are basically two months behind where we wanted to be," Pascal Soriot told German daily Die Welt in an interview, when asked about delayed deliveries in Europe. "And the issue here is we've had also teething issues like.this in the UK supply chain," he added. "As for Europe, we are three months behind in fixing those glitches." ... In August last year, the EU agreed to purchase 300 million doses of AstraZeneca's vaccine for 750 million euros, with an option for an additional 100 million. That was after Britain in May secured 100 million doses for 84 million pounds and the United States, also that month, secured 300 million doses for up to $1.2 billion. Soriot, however, said the volumes agreed with the EU were not binding.
AstraZeneca's Chief Executive on Tuesday said the European Union's late decision to strike a contract with the drugmaker to supply COVID-19 vaccines, months after Britain, meant the company did not have enough time to iron out glitches in setting up production lines with external partners.
"We are basically two months behind where we wanted to be," Pascal Soriot told German daily Die Welt in an interview, when asked about delayed deliveries in Europe.
"And the issue here is we've had also teething issues like.this in the UK supply chain," he added. "As for Europe, we are three months behind in fixing those glitches."
...
In August last year, the EU agreed to purchase 300 million doses of AstraZeneca's vaccine for 750 million euros, with an option for an additional 100 million.
That was after Britain in May secured 100 million doses for 84 million pounds and the United States, also that month, secured 300 million doses for up to $1.2 billion.
Soriot, however, said the volumes agreed with the EU were not binding.
Never ever read so many much Bull in a short article ... ‼️
That's best effort??
Purchase price EU 2.50 UK £0.84 US $4.- I'm sure the above doesn't tell the whole story of the contract. AstraZeneca has excellent outsource partners in Europe ... it seems more likely the vaccine didn't perform or met FDA Standards ... yet ... thus no build-up of stock.
FDA: COVID-19 vaccines in development - Jan. 15, 2021 Amnesia and Gaza Genocide
by gmoke - Nov 11
by gmoke - Nov 7
by gmoke - Nov 6
by gmoke - Oct 27
by Oui - Nov 14
by Oui - Nov 13
by Oui - Nov 12
by Oui - Nov 11
by Oui - Nov 103 comments
by Oui - Nov 9
by Oui - Nov 8
by Oui - Nov 64 comments
by Oui - Nov 52 comments
by Oui - Nov 4
by Oui - Nov 24 comments
by Oui - Nov 2
by Oui - Nov 14 comments
by Oui - Oct 31
by Oui - Oct 301 comment